These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2563772)

  • 1. 3-aminopyridazine derivatives with atypical antidepressant, serotonergic, and dopaminergic activities.
    Wermuth CG; Schlewer G; Bourguignon JJ; Maghioros G; Bouchet MJ; Moire C; Kan JP; Worms P; Biziere K
    J Med Chem; 1989 Mar; 32(3):528-37. PubMed ID: 2563772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis and antidepressive effects of diaryl-4,6-amino-3-pyridazine analogs of minaprine].
    Coudert P; Rubat C; Couquelet JM; Bastide J
    Farmaco Sci; 1988 Oct; 43(10):793-800. PubMed ID: 3240830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minaprine, a new drug with antidepressant properties.
    Bizière K; Worms P; Kan JP; Mandel P; Garattini S; Roncucci R
    Drugs Exp Clin Res; 1985; 11(12):831-40. PubMed ID: 3836113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic and serotonergic activities of imidazoquinolinones and related compounds.
    Moon MW; Morris JK; Heier RF; Chidester CG; Hoffmann WE; Piercey MF; Althaus JS; Von Voigtlander PF; Evans DL; Figur LM
    J Med Chem; 1992 Mar; 35(6):1076-92. PubMed ID: 1348089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacologic profile of an original psychotropic drug. Minaprine: comparison with six reference antidepressives].
    Worms P; Kan JP; Perio A; Wermuth CG; Bizière K; Roncucci R
    J Pharmacol; 1986; 17(2):126-38. PubMed ID: 3489135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
    J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT1A-receptor antagonism: N-alkyl derivatives of (R)-(-)-8,11-dimethoxynoraporphine.
    Cannon JG; Jackson H; Long JP; Leonard P; Bhatnagar RK
    J Med Chem; 1989 Aug; 32(8):1959-62. PubMed ID: 2569041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant activity of new 3-amino-5-disubstituted benzylidene-6-methyl-(4H)-pyridazine derivatives.
    Rubat C; Coudert P; Bastide P; Tronche P
    Chem Pharm Bull (Tokyo); 1988 Dec; 36(12):5000-3. PubMed ID: 3246058
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of new serotonergic 2-substituted 4,6-diaryl pyridazin-3-ones.
    Castanier L; Rubat C; Coudert P; Albuisson E; Chopineau J; Couquelet J
    Arzneimittelforschung; 1995 Sep; 45(9):947-51. PubMed ID: 7488310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms in the action of minaprine.
    Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):629-37. PubMed ID: 2851858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and pharmacological evaluation of enantiomers of certain nonoxygenated aporphines: (+)- and (-)-aporphine and (+)- and (-)-10-methylaporphine.
    Cannon JG; Raghupathi R; Moe ST; Johnson AK; Long JP
    J Med Chem; 1993 May; 36(10):1316-8. PubMed ID: 8098770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug.
    Bizière K; Kan JP; Souilhac J; Muyard JP; Roncucci R
    Arzneimittelforschung; 1982; 32(8):824-31. PubMed ID: 6890359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminopyridazines as acetylcholinesterase inhibitors.
    Contreras JM; Rival YM; Chayer S; Bourguignon JJ; Wermuth CG
    J Med Chem; 1999 Feb; 42(4):730-41. PubMed ID: 10052979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy.
    Hallot A; Brodin R; Merlier J; Brochard J; Chambon JP; Biziere K
    J Med Chem; 1986 Mar; 29(3):369-75. PubMed ID: 3950916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of serotonin neurotransmission and inhibition of mouse-killing behavior: III. Effects of minaprine, CM 30366 and SR 95191.
    Isel F; Mandel P
    Pharmacol Biochem Behav; 1989 Jul; 33(3):655-62. PubMed ID: 2531423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect.
    Pytka K; Podkowa K; Rapacz A; Podkowa A; Żmudzka E; Olczyk A; Sapa J; Filipek B
    Pharmacol Rep; 2016 Apr; 68(2):263-74. PubMed ID: 26922526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptake.
    Bøgesø KP; Christensen AV; Hyttel J; Liljefors T
    J Med Chem; 1985 Dec; 28(12):1817-28. PubMed ID: 2999402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminopyridazines--an alternative route to potent muscarinic agonists with no cholinergic syndrome.
    Wermuth CG
    Farmaco; 1993 Feb; 48(2):253-74. PubMed ID: 8494598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.